RAPGEF4 and diabetes mellitus: Additionally, exploring combined intervention strategies involving the PKA/EPAC pathway with other key metabolic pathways is necessary to overcome the vicious cycle between diabetes and lipid metabolism disorders and to develop tissue-specific delivery systems to achieve precise targeting of key tissues, such as the liver and islets, by drugs, thereby enhancing the therapeutic effect and reducing side effects.